Biophytis (EPA:ALBPS)

BRIEF

published on 03/24/2025 at 07:35, 10 months 6 days ago

Biophytis Reveals New Preclinical Findings on Obesity Treatment

Biophytis Obesity Treatment GLP-1 Preclinical Results Muscle Strength
REGULATED PRESS RELEASE

published on 03/24/2025 at 07:30, 10 months 6 days ago

Biophytis announces new non-clinical data further supporting its mission to pioneer the restoration of mobility in patients with obesity
Biophytis announces new preclinical study results showing combination of BIO101 and GLP-1 restores muscle strength and mobility in obesity patients. The company aims to pioneer mobility restoration in obese patients

Biophytis Preclinical Study BIO101 Obesity GLP-1
BRIEF

published on 03/17/2025 at 07:05, 10 months 13 days ago

Biophytis Publishes Promising Sarcopenia Trial Results

Biophytis Clinical Trial Sarcopenia BIO101 Phase 2 Results
REGULATED PRESS RELEASE

published on 03/17/2025 at 07:00, 10 months 13 days ago

Biophytis revolutionizes sarcopenia
Biophytis announces groundbreaking results from SARA-INT Phase II trial for BIO101 in sarcopenia, confirming Phase 3 readiness. Publication in JCSM highlights efficacy and safety

Biophytis Clinical Trial Sarcopenia Phase II SARA-INT
BRIEF

published on 03/06/2025 at 07:05, 10 months 24 days ago

Biophytis to Attend BIO-Europe Spring 2025 in Milan

Biophytis Biotechnology Drug Development BIO-Europe 2025 Aging Diseases
REGULATED PRESS RELEASE

published on 03/06/2025 at 07:00, 10 months 24 days ago

Biophytis announces its participation to the BIO-Europe Spring 2025 in Milan
Biophytis announces participation in BIO-Europe Spring 2025 in Milan. Chief Business Officer to attend meetings. Focus on lead drug candidate BIO101 in obesity and sarcopenia

Biophytis Sarcopenia BIO101 Obesity BIO-Europe Spring 2025
BRIEF

published on 02/25/2025 at 07:05, 11 months 5 days ago

Biophytis to Present at 15th International Conference on Frailty and Sarcopenia Research

Biophytis Sarcopenia BIO101 ICFSR 2025 Obesity Research
REGULATED PRESS RELEASE

published on 02/25/2025 at 07:00, 11 months 5 days ago

Biophytis announces its participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)
Biophytis to participate in ICFSR 15th International Conference on Frailty and Sarcopenia Research, presenting data on BIO101 for obesity-associated sarcopenia. Event in Toulouse, March 12-14

Biophytis Sarcopenia ICFSR BIO101 Obesity
BRIEF

published on 02/11/2025 at 07:05, 11 months 19 days ago

Biophytis Outlines 2025 Strategic Plans

Strategic Partnerships Biophytis Clinical Development Obesity Treatment Sarcopenia
REGULATED PRESS RELEASE

published on 02/11/2025 at 07:00, 11 months 19 days ago

Biophytis unveils its outlook strategies for 2025
Biophytis unveils its strategic outlook for 2025, focusing on clinical development and commercialization plans for BIO101 (20-Hydroxyecdysone) in obesity and sarcopenia, with key partnerships and agreements

Biophytis Clinical Development BIO101 Obesity Strategic Outlook

Published on 01/31/2026 at 03:15, 1 hour 58 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 2 hours 53 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 3 hours 33 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 5 hours 13 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 6 hours 13 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 2 hours 28 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 7 hours 13 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 9 hours 3 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 9 hours 3 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 9 hours 6 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 11 hours 28 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 21 hours 13 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 11 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 11 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 11 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News